Cardiovascular drugs
These companies make medicines for heart disease, high blood pressure and blood clots.
+30.4%
over 1 year · S&P 500 +11.6%
Key indicators
Health
50 / 100
Fragile
Solid
Price
P/E 28
Cheap
Expensive
Up over 1 year
9 of 18
Wallets over 90 days
1 / 3 buys / sells
Buys
Sells
Health and price: against the other tags.
Key indicators
When a figure has a bar, the marker places it among its peers, and the further right it sits, the more the figure beats the others. Green marks the best third, red the weakest and white anything in between. Some figures stay white wherever they sit, like price, pace or holding time, because neither side is better there.
The 21 companies
AMGN
+42.3%
PFE
+19.1%
BMY
+35.0%
Size: weight in the tag. Color: move over the period.
See all companies
See all companies
A
Amgen
AMGN
44.6%
+42.3%
P
Pfizer
PFE
29.5%
+19.1%
B
Bristol-Myers Squibb
BMY
22.3%
+35.0%
C
Cytokinetics
CYTK
1.4%
−14.9%
E
Edgewise Therapeutics
EWTX
0.9%
+117.0%
M
Mineralys Therapeutics
MLYS
0.3%
−67.6%
K
Kardigan
KARD
0.3%
M
MannKind
MNKD
0.2%
−21.3%
G
Monte Rosa Therapeutics
GLUE
0.2%
−33.8%
L
Lexicon Pharmaceuticals
LXRX
0.1%
+16.2%
T
Tectonic Therapeutic
TECX
<0.1%
+12.1%
R
Rocket Pharmaceuticals
RCKT
<0.1%
−30.3%
L
Lexeo Therapeutics
LXEO
<0.1%
−68.8%
T
Tenax Therapeutics
TENX
<0.1%
−76.8%
A
AstraZeneca
AZN
B
Bayer
BAYRY
+26.6%
C
City Therapeutics
CTY
K
Kiniksa Pharmaceuticals
KNSA
+137.4%
M
Mesoblast
MESO
−15.5%
N
NewAmsterdam Pharma
NAMS
−47.4%
N
Novartis
NVS
+23.7%